Literature DB >> 18838196

The ACE Insertion Deletion polymorphism relates to dementia by metabolic phenotype, APOEepsilon4, and age of dementia onset.

D R Gustafson1, L Melchior, E Eriksson, V Sundh, K Blennow, I Skoog.   

Abstract

The renin-angiotensin system (RAS) may play a role in dementia pathogenesis because of its effects on vascular and metabolic homeostasis, amyloid metabolism, and learning and memory. The angiotensin-converting enzyme (ACE), a pivotal RAS protein, is encoded for by a gene containing a functional ID variant, which has been related to dementia risk. We examined the relationship between the ACE Insertion Deletion (ACE ID) variant and dementia with consideration for metabolic phenotypes, age and APOEepsilon4 using a population-based, cross-sectional sample of 891 Swedish women and men aged 70-92 years, of whom 61 people were demented. The odds of dementia was two-fold higher among those with ACE II genotype, and ranged from 2.18 to 4.35 among those with dementia onset <or=70 years, an APOEepsilon4 allele, systolic blood pressure <160 mmHg, body mass index <25 kg/m(2), and in women only, waist circumference <or=88 cm and hip circumference <101 cm. Variations among reports on the relationship between the ACE ID polymorphism and dementia may be due to lack of consideration for gene-gene and gene-phenotype associations. Copyright 2008 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18838196     DOI: 10.1016/j.neurobiolaging.2008.07.015

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  11 in total

Review 1.  Antihypertensive Therapies and Cognitive Function: a Review.

Authors:  Nisharahmed Kherada; Todd Heimowitz; Clive Rosendorff
Journal:  Curr Hypertens Rep       Date:  2015-10       Impact factor: 5.369

2.  Personality factors moderate the associations between apolipoprotein genotype and cognitive function as well as late onset Alzheimer disease.

Authors:  Ilan Dar-Nimrod; Benjamin P Chapman; Peter Franks; John Robbins; Anton Porsteinsson; Mark Mapstone; Paul R Duberstein
Journal:  Am J Geriatr Psychiatry       Date:  2012-12       Impact factor: 4.105

3.  Gene by neuroticism interaction and cognitive function among older adults.

Authors:  Ilan Dar-Nimrod; Benjamin P Chapman; John A Robbins; Anton Porsteinsson; Mark Mapstone; Paul R Duberstein
Journal:  Int J Geriatr Psychiatry       Date:  2012-01-04       Impact factor: 3.485

4.  ACE polymorphism and use of ACE inhibitors: effects on memory performance.

Authors:  Jaqueline B Schuch; Pamela C Constantin; Vanessa K da Silva; Camila Korb; Daiani P Bamberg; Tatiane J da Rocha; Marilu Fiegenbaum; Alcyr de Oliveira; Luciana A Tisser; Fabiana M de Andrade
Journal:  Age (Dordr)       Date:  2014-04-04

5.  Cholesterol in mild cognitive impairment and Alzheimer's disease in a birth cohort over 14 years.

Authors:  P Toro; Ch Degen; M Pierer; D Gustafson; J Schröder; P Schönknecht
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11-17       Impact factor: 5.270

Review 6.  The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE.

Authors:  Rita J Guerreiro; Deborah R Gustafson; John Hardy
Journal:  Neurobiol Aging       Date:  2010-07-01       Impact factor: 4.673

7.  Increased Risk of Dementia in Subjective Cognitive Decline if CT Brain Changes are Present.

Authors:  Simona Sacuiu; Marie Eckerström; Lena Johansson; Silke Kern; Robert Sigström; Guo Xinxin; Svante Östling; Ingmar Skoog
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

8.  Epidemiology Informs Randomized Clinical Trials of Cognitive Impairments and Late-Onset, Sporadic Dementias.

Authors:  Deborah R Gustafson
Journal:  J Neurol Neuromedicine       Date:  2018

Review 9.  Hypertension, brain damage and cognitive decline.

Authors:  Dariusz Gąsecki; Mariusz Kwarciany; Walenty Nyka; Krzysztof Narkiewicz
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

10.  ACE gene missense mutation in a case with early-onset, rapid progressing dementia.

Authors:  Jing Ni; Shifu Xiao; Xia Li; Lin Sun
Journal:  Gen Psychiatr       Date:  2019-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.